Experiments in a Parkinson's rat model.
Pallini
R
R
Consales
A
A
Lauretti
L
L
Fernandez
E
E
D000818:Animals; D004298:Dopamine / Q000502:physiology; D005456:Fluorescent Dyes / Q000378:metabolism*; D015316:Genetic Therapy; D005822:Genetic Vectors; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009410:Nerve Degeneration; D009414:Nerve Growth Factors / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000235:genetics*; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents; D016627:Oxidopamine / Q000494:pharmacology; D010300:Parkinson Disease / Q000473:pathology / Q000628:therapy*; D051381:Rats; D013266:Stilbamidines; D013378:Substantia Nigra / Q000378:metabolism / Q000473:pathology*
C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; D005456:Fluorescent Dyes; C495041:Gdnf protein, rat; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents; D013266:Stilbamidines; D016627:Oxidopamine; D004298:Dopamine